Treatment of metastatic renal cancer with high-dose interleukin-2 after targeted therapy.

被引：0
|
作者：
Hawkins, Robert E.
Galvis, Victoria
Shanks, Jonathan
Dalal, Neha
Thistlethwaite, Fiona
Spencer-Shaw, Andrea
机构：
[1] Christie Canc Res UK, Manchester, Lancs, England
[2] Christie, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Successful treatment of a patient on adrenal steroid replacement therapy high-dose bolus interleukin-2 for metastatic renal cell carcinoma
    Deshpande, H
    Dutcher, JP
    Novik, Y
    Oleksowicz, L
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (01): : 52 - 53
  • [22] High-Dose Intensity Pulse Interleukin-2 with Famotidine in Metastatic Kidney Cancer
    Quan, Walter D. Y., Jr.
    Quan, Francine M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (02) : 181 - 183
  • [23] Nausea and vomiting during high-dose interleukin-2 (HD IL-2) therapy.
    Fesler, Mark
    Chu, Melinda Bernabe
    Armbrecht, Eric
    Fosko, Scott
    Hsueh, Eddy C.
    Richart, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2
    ROSENBERG, SA
    YANG, JC
    TOPALIAN, SL
    SCHWARTZENTRUBER, DJ
    WEBER, JS
    PARKINSON, DR
    SEIPP, CA
    EINHORN, JH
    WHITE, DE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12): : 907 - 913
  • [25] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Ajjai Alva
    Gregory A. Daniels
    Michael K. K. Wong
    Howard L. Kaufman
    Michael A. Morse
    David F. McDermott
    Joseph I. Clark
    Sanjiv S. Agarwala
    Gerald Miletello
    Theodore F. Logan
    Ralph J. Hauke
    Brendan Curti
    John M. Kirkwood
    Rene Gonzalez
    Asim Amin
    Mayer Fishman
    Neeraj Agarwal
    James N. Lowder
    Hong Hua
    Sandra Aung
    Janice P. Dutcher
    Cancer Immunology, Immunotherapy, 2016, 65 : 1533 - 1544
  • [26] CARDIOMYOPATHY ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    BECK, AC
    WARD, JH
    HAMMOND, EH
    WRAY, RB
    SAMLOWSKI, WE
    WESTERN JOURNAL OF MEDICINE, 1991, 155 (03): : 293 - 296
  • [27] Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
    Alva, Ajjai
    Daniels, Gregory A.
    Wong, Michael K. K.
    Kaufman, Howard L.
    Morse, Michael A.
    McDermott, David F.
    Clark, Joseph I.
    Agarwala, Sanjiv S.
    Miletello, Gerald
    Logan, Theodore F.
    Hauke, Ralph J.
    Curti, Brendan
    Kirkwood, John M.
    Gonzalez, Rene
    Amin, Asim
    Fishman, Mayer
    Agarwal, Neeraj
    Lowder, James N.
    Hua, Hong
    Aung, Sandra
    Dutcher, Janice P.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (12) : 1533 - 1544
  • [28] Effects of total parenteral nutrition (TPN) during high-dose interleukin-2 treatment for metastatic cancer
    Samlowski, WE
    Wiebke, G
    McMurry, M
    Mori, M
    Ward, JH
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01): : 65 - 74
  • [29] Metastatic renal cell carcinoma: Long-term survival after therapy with high-dose continuous-infusion interleukin-2
    Gold, PJ
    Thompson, JA
    Markowitz, DR
    Neumann, S
    Fefer, A
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S85 - S91
  • [30] Single-institution experience of high-dose interleukin-2 therapy for metastatic melanoma
    Chu, Melinda
    Hsueh, Eddy
    Armbrecht, Eric
    Richart, John
    Fosko, Scott
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB154 - AB154
12345